Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Lung Cancer

  Free Subscription


1 Am J Clin Oncol
1 Ann Surg Oncol
3 Ann Thorac Surg
6 BMC Cancer
1 Cancer Cell
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
2 Carcinogenesis
1 Clin Cancer Res
3 Clin Lung Cancer
1 Clin Nucl Med
2 Eur J Cancer
2 Eur J Cardiothorac Surg
1 Hum Pathol
1 Int J Cancer
1 Int J Oncol
2 J Cancer Res Clin Oncol
2 J Thorac Cardiovasc Surg
1 J Thorac Oncol
1 JAMA Oncol
1 Lancet
2 Lung Cancer
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Oncol

  1. XU J, Tian L, Qi W, Lv Q, et al
    Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
    Am J Clin Oncol. 2024;47:291-303.
    PubMed         Abstract available

    Ann Surg Oncol

  2. AL-KASSPOOLES M, Wilkerson J
    Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15406.

    Ann Thorac Surg

  3. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
    Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
    Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
    PubMed         Abstract available

    Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1119-1120.

  5. YANG F, Sun K, Li F, Li X, et al
    The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1111-1119.
    PubMed         Abstract available

    BMC Cancer

  6. HAYASHI Y, Ueyama A, Funaki S, Jinushi K, et al
    In situ analysis of CCR8(+) regulatory T cells in lung cancer: suppression of GzmB(+) CD8(+) T cells and prognostic marker implications.
    BMC Cancer. 2024;24:627.
    PubMed         Abstract available

  7. LI W, Wu J, Jia Q, Shi Y, et al
    PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
    BMC Cancer. 2024;24:633.
    PubMed         Abstract available

  8. ZHAO W, Liu Y, Yang Y, Wang L, et al
    New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
    BMC Cancer. 2024;24:635.
    PubMed         Abstract available

  9. LIN X, Wang F, Li Y, Lei F, et al
    Exploring shared decision-making needs in lung cancer screening among high-risk groups and health care providers in China: a qualitative study.
    BMC Cancer. 2024;24:613.
    PubMed         Abstract available

  10. PRETE M, Ballarin G, Porciello G, Arianna A, et al
    Bioelectrical impedance analysis-derived phase angle (PhA) in lung cancer patients: a systematic review.
    BMC Cancer. 2024;24:608.
    PubMed         Abstract available

  11. LIAO S, Wang Y, Zhou J, Liu Y, et al
    Associations between chronic obstructive pulmonary disease and ten common cancers: novel insights from Mendelian randomization analyses.
    BMC Cancer. 2024;24:601.
    PubMed         Abstract available

    Cancer Cell

  12. FINLAY JB, Ireland AS, Hawgood SB, Reyes T, et al
    Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer.
    Cancer Cell. 2024 May 20:S1535-6108(24)00164-8. doi: 10.1016/j.ccell.2024.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  13. MURPHY SE, Guillermo C, Thomson NM, Carmella SG, et al
    Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available

    Cancer Lett

  14. HE Q, Qu M, Xu C, Wu L, et al
    Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation.
    Cancer Lett. 2024;592:216922.
    PubMed         Abstract available

  15. GUGNONI M, Lorenzini E, Torricelli F, Donati B, et al
    Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma.
    Cancer Lett. 2024;592:216950.
    PubMed         Abstract available


  16. PAN C, Wang Q, Wang H, Deng X, et al
    LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Carcinogenesis. 2024;45:311-323.
    PubMed         Abstract available

  17. WEI S, Ai M, Zhan Y, Yu J, et al
    TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway.
    Carcinogenesis. 2024;45:324-336.
    PubMed         Abstract available

    Clin Cancer Res

  18. FUKUDA A, Okuma Y
    From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2024 May 20. doi: 10.1158/1078-0432.CCR-23-4035.
    PubMed         Abstract available

    Clin Lung Cancer

  19. NONAKA Y, Isaka M, Matsushima K, Katsumata S, et al
    Prediction of Pleural Lavage Cytology According to Thin-Section Computed Tomography in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2024 Apr 16:S1525-7304(24)00053.
    PubMed         Abstract available

  20. SRIDHAR A, West HJ, Singhi EK
    Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00068.
    PubMed         Abstract available

  21. ROBERTS HN, Solomon B, Harden S, Lingaratnam S, et al
    Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.
    Clin Lung Cancer. 2024 Apr 6:S1525-7304(24)00045.
    PubMed         Abstract available

    Clin Nucl Med

  22. CHUN IK, Lee S
    Papillary Thyroid Cancer, Small Cell Lung Cancer, and Parathyroid Adenoma Synchronously Visualized on 99mTc-MIBI SPECT/CT in a Patient With Hyperparathyroidism: Comparison With 18F-FDG PET/CT.
    Clin Nucl Med. 2024 May 23. doi: 10.1097/RLU.0000000000005267.
    PubMed         Abstract available

    Eur J Cancer

  23. BLASI M, Kuon J, Luders H, Misch D, et al
    Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
    Eur J Cancer. 2024 May 24:114130. doi: 10.1016/j.ejca.2024.114130.

  24. CARRIL-AJURIA L, Lavaud P, Dalban C, Negrier S, et al
    Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
    Eur J Cancer. 2024;204:114048.
    PubMed         Abstract available

    Eur J Cardiothorac Surg

  25. LI K, Li B, Yang J
    Optimal lymphadenectomy should be based on number or location or both?
    Eur J Cardiothorac Surg. 2024;65:ezae190.

  26. Corrigendum to: Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes; Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?; and Subloba
    Eur J Cardiothorac Surg. 2024;65:ezae203.

    Hum Pathol

  27. SUN W, Qu L, Wu J, Liu X, et al
    "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
    Hum Pathol. 2024 May 21:S0046-8177(24)00093.
    PubMed         Abstract available

    Int J Cancer

  28. WANG Z, Zhang Q, Wang C, Herth FJF, et al
    Multiple primary lung cancer: Updates and perspectives.
    Int J Cancer. 2024 May 23. doi: 10.1002/ijc.34994.
    PubMed         Abstract available

    Int J Oncol

  29. TAYLOR J, Dubois F, Bergot E, Levallet G, et al
    Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
    Int J Oncol. 2024;65:68.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  30. LI X, Wu D, Tang J, Wu Y, et al
    The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
    J Cancer Res Clin Oncol. 2024;150:271.
    PubMed         Abstract available

  31. WANG X, Xu Z, Zhao S, Song J, et al
    A novel subtype based on driver methylation-transcription in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2024;150:269.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  32. YAN H, Niimi T, Matsunaga T, Fukui M, et al
    Preoperatively Predicting Survival Outcome for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer by Radiomics-based Machine Learning.
    J Thorac Cardiovasc Surg. 2024 May 22:S0022-5223(24)00441.
    PubMed         Abstract available

  33. XU L, Si H, Zhuang F, Li C, et al
    Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 May 17:S0022-5223(24)00437.
    PubMed         Abstract available

    J Thorac Oncol

  34. ROCCO G, Pennazza G, Tan KS, Vanstraelen S, et al
    A real-world assessment of stage I lung cancer through electronic nose technology.
    J Thorac Oncol. 2024 May 16:S1556-0864(24)00211.
    PubMed         Abstract available

    JAMA Oncol

  35. CHAUNZWA TL, Qian JM, Li Q, Ricciuti B, et al
    Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.
    JAMA Oncol. 2024 May 23. doi: 10.1001/jamaoncol.2024.1120.
    PubMed         Abstract available


  36. GIJTENBEEK RG, Noordhof AL, Asmara OD, Groen HJ, et al
    Immunotherapy in frail non-small-cell lung cancer patients.
    Lancet. 2024;403:1986.

    Lung Cancer

  37. FELIP E, Metro G, Tan DSW, Wolf J, et al
    Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer.
    Lung Cancer. 2024;192:107820.
    PubMed         Abstract available

  38. LI Y, Wong M, Zhan L, Corke L, et al
    Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
    Lung Cancer. 2024;192:107823.
    PubMed         Abstract available

    PLoS One

  39. BIANCHI F, Le Noci V, Bernardo G, Gagliano N, et al
    Cigarette smoke sustains immunosuppressive microenvironment inducing M2 macrophage polarization and viability in lung cancer settings.
    PLoS One. 2024;19:e0303875.
    PubMed         Abstract available

  40. LUO W, Chang G, Lin D, Xie H, et al
    3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
    PLoS One. 2024;19:e0303186.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.